Published On : 17 Oct 2016
The number of pharmaceutical companies using mobile apps is increasing at a significant pace. Leading pharma companies are using various android apps to take care of their routine activities. Currently, key companies are targeting the untapped market to increase their share in the global pharma app benchmarking market. The introduction of new mobile apps for the pharma companies is expected to propel the market, finds a new report added to the database of QYResearchReports.com.
The report, titled “Global Pharma App Benchmarking Market Professional Survey Report 2016,” briefs readers about the various apps, android and iOS, which are used by the leading pharmaceutical companies. A detailed benchmarking of the activities of leading pharmaceutical companies on the mobile apps is highlighted in the report by the analysts. For a detailed study on the benchmarking, a comparison of active users, application category, downloads, and target groups is considered. Factors such as the performance of various pharma apps and the frequency of use by the leading pharma companies are studied by the analysts in the report.
A detailed profile of all pharma companies is listed in the report on the global pharma app benchmarking marker. Key companies operating in this global market are profiled with details such as product specification, application, specifications, ex-factory price, gross, revenue, and margin analysis. For a detailed analysis of strengths, weaknesses, opportunities, and threats of key companies, industry-standard tools such as SWOT analysis and Porter’s five force analysis are used by the analysts.
To get sample copy of report visit @ https://www.qyresearchreports.com/sample/sample.php?rep_id=812544&type=E
New project developments and the feasibility of the new projects are also studied in the report. The adoption of changing trends will benefit the key companies operating in this market, predict the analysts. Key companies are focusing on increasing their research and development activities for the discovery of new mobile apps for the pharma companies. For a detailed competitive analysis, the global pharma app benchmarking market is regionally divided into Europe, North America, Southeast Asia, and other regions.
Abbott, Astra Zeneca, Bayer HealthCare, Bristol-Myer Squibb, GlaxoSmithKline, Johnson&Johnson, Merck, MSD, Novartis, Pfizer, Roche, and Sanofi-Aventis are some of the key companies operating in the global pharma app benchmarking market. Some of the key companies are also engaged in acquiring the startup companies willing to participate in the mainstream. While leading companies aim to maintain their dominance, the startup companies are expected to avail a chance to adopt new technologies and trends.
The global pharma app benchmarking market is segmented on the basis of region, application, and type. Key companies operating in the global market are focusing on introducing new types of mobile apps for the pharma companies. The introduction of new smartphones and the advent of technology has led to the development of new apps. The rising application of pharma apps is expected to benefit the global market in the near future. The demand for health insurance apps, diabetes apps, and various other apps is expected to increase, which will propel the global market.